Frontlight ResearchEarly access
CompletedNo phase
Hormone Evaluation in Artificial Reproductive Technology
Key facts
- Who runs it
- Lund University
- Where
- Poland and Sweden2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 810 people enrolled
- Started
- Sept 2016
- Ended
- 2 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Follitropin alpha
- Menotropin
- Record updated
- 17 March 2025
Who can take part
- Age
- 25 years to 40 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Normal ovulatory cycles 26-32 days
- First and second IVF treatment
- Indication for IVF is male factor, tubal factor or unexplained infertility
- Medical indication for IVF; >12 months unprotected intercourse
Who cannot take part
- polycystic ovarian syndrome
- pre ovarian failure
- male age more than 56
- Anti Müllerian Hormone <5pmol or cycle day 2-3 FSH >12
- Endometriosis
- smoking
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation.
Read full original descriptionShow less
Outcome will be measured as pregnancy success, live born babies and unwanted side effects.
The 2 groups in the trial
- Follitropin alphaExisting treatment, for comparison
Follitropin alpha (GONAL-f, Merck-Serono, Darmstadt, Germany), injections, dosage varying 1500-2500 IU, duration 2-5 days.
Treatment: Follitropin alpha and Menotropin
- MenotropinExisting treatment, for comparison
Menotropin (Menopur, Ferring GmbH, Kiel, Germany), injections, dosage varying 1500-2500 IU, duration 2-5 days.
Treatment: Follitropin alpha and Menotropin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction.
- Record updated
- 17 March 2025